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19-Iodocholesterol-125I was synthesized for study as a 
possible agent for photoscanning the adrenal gland and as- 
sociated tumors. In contrast to previous radioiodinated 
steroids, it was found to be much less prone to rapid in vivo 
delodlnatlon. Preliminary ~issue distribution studies and 
biochemical analyses have revealed a marked similarity in the 
behavior of the radiolodinated derivative with the natural 
steroid. The concentration of radioactivity in the adrenal 
cortex of dogs at 48 hours was found to greatly exceed that 
found in other organs. 
Over the past several years an effort has been made in our 
laboratories to develop a radiopharmaceutical suitable for photo- 
scanning the adrenal gland and associated tumors. Despite the rapid 
advances in Nuclear Medicine, the adrenal glands remain one of the 
few organs to be visualized by radioisotope scanning techniques. 
Similar to the use of radiolodlne in thyroid disease, a radio- 
labeled drug that selectively concentrates in the adrenal gland 
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would not only be of diagnostic value,.but also have potential 
therapeutic applications. 
Our synthetic approaches to this problem have proceeded along 
the following lines: 
I. To radiolabel drugs reported or suspected to have a pre- 
dilection for adrenal tissue, and 
2. To radlolabel naturally occurring compounds known to be 
biosynthesized and/or stored in the adrenals. 
We have previously reported the synthesis of various radiolodinated 
analogs of l-(o-chlorophenyl)-l-(£-chlorophenyl)-2,2-dichloroethane 
(~,£'-DDD) based on the reported predilection of ~,~'-DDD for adre- 
nal tissue. [2) While several of the radlolodinated analogs did 
concentrate in the dog adrenal cortex more than any other tissue 
shortly after administration, the target to non-target ratio was 
insufficient to achieve successful adrenal photoscans. 
Our alternate approach to adrenal localizing agents has been 
to investigate the feasibility of radioiodinated steroids. There 
are numerous reports in the literature citing the ability of var- 
ious radiolabeled steroid hormones to concentrate in the adrenal 
cortex. For example, Hanngren et al. (4)- observed accumulation of 
14^ ~. 
~-cor~isone in the adrenal cortex of mice five minutes after 
administration. The radioactivity soon subsided from the cortex, 
however, and very little remained 20 minutes after injection. 
Similar studies with 14C-estrone or 1 4 C - d i e t h y l s t i l b e s t r o l  showed 
that the adrenal cortex had the highest level of activity of any 
tissue examined for as long as 60 minutes following injection. (5) 
We previously reported the synthesis of 21-iodoprogesterone- 
- _ 125_ 125I and 21-iodopregnenolone acetate- ± as possible adrenal 
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scanning agents. "6'( ~ This work was prompted by the reports by 
Bengtsson et al. (7) and Laumas and Farooq (8) that uptake of radio- 
labeled progesterone by the adrenal cortex far exceeded that of any 
other tissue. In our study, however, the radioiodinated steroid 
analogs rapidly underwent in vivo deiodination, and it was quite 
apparent that other sites on the steroid nucleus less prone to en- 
zymatic dehalogenatlon would have to be found. 
It has been known for a number of years that the adrenals are 
particularly rich in cholesterol. In most animals, the adrenals 
are the richest source of cholesterol where it is present mainly 
in the esterifled form. (9) This information suggested that an 
appropriately radioiodinated cholesterol might have the features 
required for an adrenal scanning agent. 
Several papers have reported the ability of 14C-cholesterol 
to concentrate in adrenal tissue, (lO) but it was Appelgren's (ll) 
findings which prompted us to take a more serious look at utilizing 
cholesterol as a platform for radiolodine. Appelgren(ll) gave 
14C-cholesterol by I.V. injection to mice and studied the distri- 
bution at various times by whole body and detailed autoradiography. 
The strongest accumulation appeared in the adrenal cortex and at 
24 hours the level of radioactivity was about 20 times that of 
blood. A strong accumulation was also seen in the ovary and cor- 
pora lutea. More recent electron microscopic autoradlographs 
have demonstrated that most of the adrenal cholesterol is stored 
(12) 
in the lipid droplets of the adrenal cortical cells. 
Shortly after we initiated our study, Nagal, Solis and Koh (I~) 
reported on 131I-cholesterol as a possible adrenal scanning agent. 
These workers labeled cholesterol by iodination with sodium iodide- 
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1311 and chloramine-T. Although they. did not characterize their 
radloiodinated product or products, one would expect the iodine to 
add across the 5, 6-double bond to give a diiodo derivative Sub- 
sequent tissue distribution studies in mice with this agent re- 
vealed, however, that the adrenal-to-liver concentration at 24 hours 
was only 2.70 and that significant in vivo delodlnation had occured. 
These workers later found that radiolodinated stlgmasterol prepared 
in a similar manner was superior to the cholesterol derivative in 
its ability to concentrate in the adrenals, but the target to non- 
target ratio was still insufficient for radiographic delineation 
of these organs. 
In our own studies, we attempted to find a position on the 
steroid molecule that could be readily functionalized with iodine 
but which at the same time would not markedly alter the basic cho- 
lesterol structure. In addition, the position would have to be 
somewhat resistant to in vivo dehalogenation. On this basis, sub- 
stitution at the neopentyl, C-19 position of cholesterol seemed a 
logical choice for our initial studies. Cholest-5-ene-3,19-diol 
3-acetate was prepared in a manner similar to that described by 
Kalvoda et a l .  (14) Treatment of this alcohol with ~-toluenesul- 
fonyl chloride in pyridine afforded the desired tosylate, I. 
Selective hydrolysis of the acetate ester of I gave II which was 
subsequently treated with sodium iodide in isopropanol to yield 
19-iodocholesterol (III). Radiolodination was readily achieved 
by isotope exchange of III with sodium iodide-125 in refluxing 
acetone. 19-1odocholesterol acetate-125I (IV) was prepared from 
I in a similar manner. 
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TsOCH2 ~ ~ ICH 
R0 ~ R 0 ~  
I R = Ac III R = H 
II R = H IV R = Ac 
Tissue distribution studies in dogs with 19-iodocholesterol- 
125I have been completed and the details are reported elsewhere. (15) 
In brief, the radioiodinated derivative was found to behave remark- 
ably similar to the natural steroid. Table I compares the tissue 
distribution of radioiodinated cholesterol with that found for cho- 
lesterol-4-14C in dogs at 48 hours. In all instances the concen- 
tration of radioactivity in the adrenal cortex was found to greatly 
exceed that in other organs. The high radioactivity found in the 
thyroids of the dogs receiving the radioiodinated derivative, par- 
ticularly the dog not previously dosed with potassium iodide solu- 
tion, reflects the expected in vivo metabolism and deiodination 
of the compound. 
For purposes of photoscanning, it was important that the 
concentration of radioactivity in the adrenal gland be consider- 
ably greater than the nearest major organs, liver andkidney. In 
• 12 = all three dogs receiving 19-1odocholesterol- ~I, the adrenal cor- 
tex-to-liver and adrenal cortex-to-kidney ratios were approximately 
30, and this value has been found to exceed I00 at 8 days after 
administration. (I~) This selective concentration of 19-iodocholes- 
J % 
12 ~ 
terol- ~I in the adrenal cortex has made it possible to visualize 
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( 1 6 )  " 
Extraction of the adrenal cortices by the Folch procedure 
revealed that all of the radioactivity was contained in the chloro- 
form phase and none in the methanol-water phase. There appeared, 
therefore, to be no inorganic iodide-125 in the adrenals after the 
injection of 19-iodocholesterol-125I. 
The analysis of the chloroform phase from 19-iodocholesterol- 
125I treated dogs showed much greater variation from results ob- 
tained with a similar extract of the cholesterol-4-14C adrenals. 
In the former, a significant amount of radioactivity always was 
associated with the cholesterol-ester fraction (25-35~). Only 
small amounts were found in the cholesterol fraction (4-6~) and 
the remainder stayed at the origin. In the case of the cholesterol- 
4-14C adrenal extract, 80-85% of the radioactivity was located 
in the cholesterol ester fraction and the rest migrated as free 
cholesterol. 
In several cases, the radioiodinated cholesterol-ester frac- 
tion was extracted from the tlc plate and rechromatographed in the 
same solvent system. The lipid staining material again moved with 
the ester fraction, but only 24~ of the radioactivity could be re- 
covered from this fraction. The variability in the chromatographic 
distribution of 125I radioactivity and the failure of the radioactiv 
ity to migrate with the lipid when rechromatographed is probably 
the result of the instability of 19-iodocholesterol under the con- 
ditions of analysis. This instability also has hampered attempts 
to rigorously characterize the chemical structure of the radioiodi- 
hated ester fraction. 
Since 19-iodocholesterol was apparently capable of in vivo 
esterficatlon in a manner similar to cholesterol, it seemed possible 
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that certain radioiodinated adrenocorticosteroids and their excre- 
tory metabolltes might also be formed. However, analysis of 
urine samples obtained from the bladder of one of the dogs treated 
with 19-iodocholesterol-125I revealed no radioiodinated steroid 
metabolites and all of the urinary radioactivity could be accounted 
for as inorganic iodide. Additional studies are now in progress 
to evaluate 19-iodocholesterol-125I as a biochemical tool. 
EXPEHIMENT~J ( 17 ) 
Cholest-5-ene-~B~19-diol 19-toluene-p-sulfonate (II). -- A 
solutig~egf cholest-5-ene-3B,19-diol 3-acetate 19-toluene-p-sul- 
fonate ~j (I, 200 rng) in dioxane (7 ml) was added dropwlse to a 
solution of Na0H (i00 mg) in aqueous methanol (i0 ml). The solu- 
tion was stirred at room temperature for 2 hr. and then poured 
into Ice-water. The resulting mixture was extracted with ether 
and the extract washed with water and dried over anhydrous sodium 
sulfate. Removal of the solvent and crystallization of the resi- 
due from acetone-water afforded pure II (120 mg, 52~): mp 121-123°; 
nmr~ 0.58 (s,3, C78-protons)~ 2.53(s,3, CH~C~H4-), 3.95 and 4.09 
(d,2, Jgem=lOcps,C~o-protons), 5.50(s~l,v~n~lic proton), 7.31 and 
7.73 (dd,4, Jo=8Cps~ aromatic protons). 
Anal. Calcd for C34H52S04: C,73.33; H,9.41. Found: C,73.77; 
H,9.55. 
19-Iodocholest-5-en-38-ol (III). -- A solution of II (200 mg) 
and sodium iodide (i00 mg) in Isopropanol (15 ml) was gently refluxed 
under nitrogen for 4 hr. The solution was concentrated to about 
5 ml in vacuo and poured into ice-water. Extraction with ether 
and work up as above furnished an oily residue which solidified 
upon trlturation with petroleum ether (bp 30-400). Recrystalliza- 
tion from methanol gave pure III(ll5 mg. 62~): mp 106-109°; nmr6 0.69 
(s,~,C,o-protons), ~ 24 and R 51 (dd,2,Jgem-llcps, -protons) 
and 5.~Z (s,l,vinylic proton~. C19 " " 
Anal. Calcd for C27H4510: 0,63.27; H,8.85. Found: C,63.45; 
H,8.91. 
19-1odocholest-5-en-3~-ol acetate (IV). -- A solution of I 
(200 mg) and sodium iodide (200 mg) in Isopropanol (20 ml) was treated 
as above. Recyrstallization of the crude productofrom acetos~ 
methanol afforded pure IV (Ii0 mg, 42~): mo 91-93 (reported L±N) mp 
97 ); nmr6 0.76 (s,3je,n protons), 2.0 (s,~, CHACO0-), 3.30 and 3..54 
{dd,2,Jgem=ll cps,Clg-~9otons), and 5.61 (s,l,~Ynyllc proton). 
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Calcd for C29H47102: C,62.79; H,8.54. Found: C,62.78; 
Radioiodinated Steroids - Isotope Exchanse: 
A. A solution of Na1251 (5 mc) was placed in a 25 ml round 
bottom flask and the water removed by azeotropic distillation with 
benzene. A solution of III (I00 mg) in acetone (7 ml) was added 
and the mixture refluxed under an atmosphere of nitrogen for 4 hr. 
The solution was allowed to cool and poured into water. The result- 
ing mixture was extracted with ether and the ether extract washed 
with water and dried over anhydrous sodium sulfate. The ether was 
evaporated and the residue chromatographed over alumina (activity 
III). Elution with~troleum ether (bp 30-40°)-ether (I:I) gave 
19-iodocholesterol-a~I (80 mg) with a specific activity of 28.25 
#Ci/mg (52~ exchange). Thin layer chromatography using chloroform- 
ethanol (i:i) gave a single spot (Rf=0.66) coincident with the sin- 
gle radioactive peak appearing on the radiochromatogram. 
B. Water from Na125I solution (3 mc) was removed as described 
above. A solution of IV (I00 mg) in acetone (5 ml) was added and the 
clear solution gently refluxed with stirring for 4 hr. under 
nitrogen. The solution was concentrated to about 1/2 the origi- 
nal volume and poured into ice water. The precipitate was col- 
lected, washed well with water, and recrystalli~6~ from methanol- 
acetone. This gave 19-iodocholesterol acetate-~I with a specific 
activity of 8.87 uCi/mg (68~ exchange). Tlc using benzene: hexane 
(1:2) showed a single spot (R~=O.Zh) coincident with the radio- 
active area shown by a radiochromatogram. 
Tissue Distribution Studies: Cholesterol-4-14C in benzene solution 
was obtained from New England Nuclear Corporation, Boston, Mass. 
and the benzene wa@dremoved by distillation under reduced p sure. 
The cholesterol-4_ a C thus obtained and 19-iodocholesterol_[~ I 
were both dissolved in 90~ ethanol such that the resulting solu- 
tions contained 100-200 ~Ci/ml. 
Each dog was given 50-150 ~Ci of radiolabeled steroid by in- 
Jection into the foreleg vein and the syringe was flushed twice with 
blood. The dogs were sacrificed at 48 hours by injection of rapid- 
acting lethal solution (Haver-Lockhart Laboratories, Kansas City, 
Missouri). 
In all dogs, 17 to 20 tissues were routinely dissected free, 
cleaned of fat and foreign material, and weighed. All tissues were 
done in duplicate and additional samples were obtained of tissue 
of special interest. The adrenals were the first tissues to be re- 
moved, wq~ghed, and then frozen for separation of cortex from me- 
dulla. ~C-labeled tissues were placed in counting vials after 
weighing, digested in 70~ NaOH (0. 3 ml) overnight, and heated for 
at least 30 seconds in near boiling water the next day to complete 
digestion. The digests were allowed t~2g~ol and 30~ HoO o (3 drops) 
and thlxotropic liquid counting system ~ vj added. TheLr~dioactive 
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contents were then assayed in a liquid scintillation system. The 
radioiodine-containlng tissues were counted directly in disposable 
plastic test tubes in an automated well counter. The concentration 
of radioactivity in each tissue was expressed in terms of the % 
administered dose/gm of tissue which was calculated as follows: 
CPM/m 5 ~ I000 x i00 
2.2 x l0 u x wCi admin, dose 
Lipid Analysis of Adrenal Cortex: The total lipid was ex~?~ted 
from the adrenal cortex by the Folch extraction procedure~ ±uj 
The chloroform extract was evaporated with a stream of nitrogen 
and the residue llpids fractionated by tlc on silica gel H. The 
solvent system hexane:ether:acetic acid(90:lO:l v/v) was used to 
separate the lipids according to their general class; phospholipids, 
sterols, fatty acids, triglycerides a@~_sterol esters. In several 
initial experiments inorganic iodide-~DI was added to adr~l cor- 
tex tissue prior to the extraction. The inorganic iodide- ~I was 
completely recovered in the methanol-water Dh~se of the extraction 
and no radioactivity from inorganic iodide-I2~I was found in the 
chloroform extract. 
Urine Analysis: Urine s~Rles (2-3 ml) obtained from a dog dosed 
with 19-1odocholesterol- ~I were chromatographed on ion exchange 
resi~2~owex-i ) according to the procedure of Galton and Pitt-Riv- 
ers." -" Inorganic iodide binds strongly to the resin and can be 
removed only with elution by ~N EBr. This w@~_verlfied for urinary 
inorganic iodide by adding inorganic iodide-~=DI to 3 ml of normal 
urine and subjecting this to the fractionation procedure. 
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